Research Article
Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension
Table 4
3-month all-cause mortality of different PH groups.
| | Pre-TAVR PH groups | Post-TAVR PH groups | Peri-TAVR PH variation groups | No PH (n = 70) | PH (n = 56) | | No PH Z(n = 90) | PH (n = 34) | | No PH (n = 61) | Improved PH (n = 35) | Persistent PH (n = 28) | |
| 3-month all-cause mortality | 4 (5.7%) | 8 (14.3%) | 0.131 | 6 (6.7%) | 4 (11.8%) | 0.460 | 2 (3.3%) | 4 (11.4%) | 4 (14.3%) | 0.057 |
|
|
TAVR, transcatheter aortic valve replacement; PH, pulmonary hypertension.
|